Why a $10 Million Bet on Core Scientific Stock Could Pay Off After Its Recent Reset

New York City-based Kintayl Capital disclosed a new stake in Core Scientific (NASDAQ:CORZ) valued at approximately $10.2 million, according to its November 14 SEC filing.Kintayl Capital LP initiated a new position in Core Scientific (NASDAQ:CORZ) during the third quarter of 2025, acquiring 570,054 shares worth an estimated $10.2 million. The transaction was disclosed in a regulatory filing with the U.S. Securities and Exchange Commission on November 14. The new stake represents 6.3% of Kintayl’s $162.2 million in reportable U.S. equity assets. SEC filingTop holdings after the filing:  Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool